Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

OPERA I and OPERA II Clinical Investigators, Andrejs Millers

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences